Back

IJOPP · Lens · Nitrofurantoin Induced Reversible Interstitial Lung Disease

PDF

Article · Volume 16, Issue 4 · pp. 366–368

Nitrofurantoin Induced Reversible Interstitial Lung Disease

Shabana Ashraf1, Sajid Salahudheen2

  1. 1Department of Clinical Pharmacy, Aster Mims Hospital, Kannur, Kerala, INDIA..
  2. 2Department of Critical Care Medicine, Aster Mims Hospital, Kannur, Kerala, INDIA..

Abstract

Drug-induced interstitial lung disease is an increasingly common cause of morbidity and mortality. Nitrofurantoin is a broad-spectrum antibiotic used for acute uncomplicated or simple cystitis as well as for prophylaxis of recurrent infection. We recently encountered a case of Nitrofurantoin-induced interstitial lung disease in an elderly patient who was on Nitrofurantoin for a year and a half for recurrent urinary tract infections. On further evaluation, she was diagnosed with drug-induced interstitial lung disease, which was confirmed by radiographic evidence. Nitrofurantoin was discontinued and managed with low-dose systemic glucocorticoids. This case report highlights the need for close vigilance of pulmonary toxicities in patients taking long-term Nitrofurantoin therapy.

Keywords: Pulmonary toxicity; Corticosteroids; Nitrofurantoin; Interstitial Lung disease; Urinary tract infection

The full text of this article is available as a PDF. Open the PDF.